Large-scale GMP SDIX specializes in high quality, large-scale GMP antibody production, all manufacturing in the USA with ISO13485:2016 certification, presenting a strong near-term opportunity for biopharma partners needing compliant, scalable antibody supply and contract manufacturing.

diversify revenue As a subsidiary of OriGene with existing immunoreagents and human serum calibrators, SDIX can cross-sell to OriGene’s customer base while expanding into contract manufacturing for multiple species, offering end-to-end antibody development and production services.

regulatory maturity ISO13485:2016 certification and USA-based production highlight a reliable, regulated supply chain ideal for diagnostics, translational research, and clinical assay developers seeking quality and traceability.

legacy partnerships Historical partnerships in technology and track-and-trace capabilities (Kynetix and Everledger) suggest openness to blockchain-enabled supply chain transparency, an area to explore for KH/QA-focused serialization and provenance solutions for critical immunoreagents.

growth readiness Revenue range ($250M–$500M) and a broad product catalog indicate capacity for new large accounts, strategic collaborations, or co-development deals with tier-one biotech and CROs seeking scalable antibody production and immunoreagent supply.